First Time Loading...

Intercept Pharmaceuticals Inc
NASDAQ:ICPT

Watchlist Manager
Intercept Pharmaceuticals Inc Logo
Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Watchlist
Price: 19 USD Market Closed
Updated: May 28, 2024

Intercept Pharmaceuticals Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intercept Pharmaceuticals Inc
Stock-Based Compensation Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Stock-Based Compensation
$24m
CAGR 3-Years
-25%
CAGR 5-Years
-15%
CAGR 10-Years
11%
Abbvie Inc
NYSE:ABBV
Stock-Based Compensation
$782m
CAGR 3-Years
-1%
CAGR 5-Years
13%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Stock-Based Compensation
$788m
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
11%
Amgen Inc
NASDAQ:AMGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Stock-Based Compensation
$650.7m
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Intercept Pharmaceuticals Inc's Stock-Based Compensation?
Stock-Based Compensation
24m USD

Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Stock-Based Compensation amounts to 24m USD.

What is Intercept Pharmaceuticals Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
11%

Over the last year, the Stock-Based Compensation growth was -4%. The average annual Stock-Based Compensation growth rates for Intercept Pharmaceuticals Inc have been -25% over the past three years , -15% over the past five years , and 11% over the past ten years .